BioXcel Therapeutics Inc (NASDAQ:BTAI)

12.11
Delayed Data
As of Jun 24
 +0.05 / +0.41%
Today’s Change
8.80
Today|||52-Week Range
36.49
-40.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization7.0K8.0K37.0K85.0K
 
 
 
 
 
 
Operating ExpensesGross Income-7.0K-8.0K-37.0K-85.0K
 
 
 
 
 
General Expenses5.1M7.3M7.4M8.6M
 
 
 
 
 
Research And Development3.8M6.0M5.7M6.5M
 
 
 
 
 
Total Operating Expenses5.1M7.3M7.4M8.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.1M-7.3M-7.4M-8.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.9M-7.1M-7.2M-8.5M
 
 
 
 
 
Net Income-4.9M-7.1M-7.2M-8.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.6M15.7M15.7M15.7M
 
 
 
 
 
Shares To Calculate EPS Diluted15.6M15.7M15.7M15.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.31-$0.46-$0.46-$0.54
 
 
 
 
 
EPS Diluted-$0.31-$0.45-$0.46-$0.54